Pro Medicus share price jumps on 36% profit growth in FY23 report

Investors are excited about the imaging technology company's healthy financials.

| More on:
Three healthcare workers look and point at at medical image

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Pro Medicus Ltd (ASX: PME) share price is up more than 6% today after the healthcare technology business released its FY23 full-year report.

The released annual result is for the 12 months to June 2023.

Initially, Pro Medicus shares opened 6.4% higher. In lunchtime trading, they remain up 6.46% at $74.12 a share.

Here are the highlights of the medical imaging technology company's full-year report:

Pro Medicus share price surges on impressive full-year result

  • Revenue grew by 33.6% to $124.9 million
  • Earnings before interest and tax (EBIT) margin of 67.2%
  • Underlying profit before tax grew by 34.5% to $83.9 million
  • Net profit after tax (NPAT) rose by 36.5% to $60.5 million
  • Final dividend increased by 36.4% to 17 cents
  • Full-year dividend up by 36.4% to 30 cents

Looking at the regional revenue breakdown, North American revenue rose 41.8% and Australian revenue increased 9.4%. Europe revenue fell 12.2% because of one-off (capital) revenue coming from the extension of the German government hospital contract in FY22, which wasn't replicated this year.

Despite sending increasingly large dividends to shareholders, the company's cash and other financial assets increased by 34.2% over the year to $121.5 million.

What else happened in FY23?

The business won a number of large contracts during the year, including a $25 million, seven-year contract with the University of Washington, a leading teaching hospital in the University District of Seattle.

According to the latest US News Best Hospital 23/24 rankings, Pro Medicus now provides imaging solutions to nine of the top 22 US hospitals, which is more than any other vendor, as well as an increasing number of large and mid-sized health organisations.

The ASX healthcare technology share noted that it has been active in terms of product development outside of its core radiology offering, as well as looking at AI.

During the year, it recruited a specialist in the cardiology space, and its two people dedicated to AI and research collaborations in the US have "been busy". It's targeting its first commercialisation in those areas within the next six months.

What did Pro Medicus management say?

Pro Medicus CEO Dr Sam Hupert said:

Cloud-based systems can be implemented much faster than those that require hardware to be bought and installed.

This, coupled with our highly modular approach, continues to provide unparalleled flexibility and scalability, as evidenced by the increasing number of clients choosing the full stack of all three Visage products – Viewer, Workflow and Archive – a trend we see continuing.

The trends we have previously identified as driving the industry continue unabated. Exponentially larger data sets, the transition to cloud and the acute global shortage of radiologists create demands that are uniquely satisfied by our Visage technology.

What's next for Pro Medicus?

Hupert said that its pipeline "continues to be strong with opportunities across all major market segments".

He believes the combination of cloud and flexibility that Pro Medicus offers in terms of modular product offerings has helped it win the majority of opportunities that it bids for, even though it supposedly has the "most expensive option on the market".

According to Pro Medicus, it can benefit from the "exponentially larger data sets, the transition to cloud and the acute global shortage of radiologists".

Pro Medicus share price snapshot

Since the start of 2023, Pro Medicus shares have risen 36%, while the S&P/ASX 200 Index (ASX: XJO) has gained around 5%.

Motley Fool contributor Tristan Harrison has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Pro Medicus. The Motley Fool Australia has recommended Pro Medicus. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Earnings Results

A man sits thoughtfully on the couch with a laptop on his lap.
Technology Shares

Up 74% in 2024, why is this ASX 200 stock rallying today?

Recurring revenues continue to grow.

Read more »

Man pointing at a blue rising share price graph.
Earnings Results

Guess which ASX All Ords share is soaring on 21% FY 2024 growth

Investors are piling into the ASX All Ords share today. Let’s find out why.

Read more »

Girl sliding down on snow with arms spread out.
Earnings Results

Elders shares on ice for a $475 million acquisition after profits plunge 55%

What on earth is going on with Elders shares today?

Read more »

A man has a surprised and relieved expression on his face. as he raises his hands up to his face in response to the high fluctuations in the Galileo share price today
Energy Shares

This ASX 200 mining stock just reported a 40% earnings jump

Investors appear pleased with this miner's performance during the first quarter.

Read more »

Business people discussing project on digital tablet.
Earnings Results

2 ASX All Ords shares surging over 10% on strong results

Investors are buying these shares in response to strong results this morning.

Read more »

A young woman holds her hand to her mouth in surprise as she reads something on her laptop.
Earnings Results

Xero share price rockets to record high on explosive half-year growth

The tech star delivered another impressive half year results this morning.

Read more »

A man cheers after winning computer game while woman sitting next to him looks upset.
Earnings Results

2 high-flying ASX 200 gaming shares splitting ways today

Which gaming giant is winning the admiration of investors amid results?

Read more »

Male building supervisor wearing high vis vest and hard hat stands and smiles with his arms crossed at a building site
Industrials Shares

This $23 billion ASX 200 stock is surging 6% while the market sinks. Here's why

This ASX 200 stock is shrugging off the wider market sell down today and racing higher. But why?

Read more »